BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 38591038)

  • 1. Substrate Affinity Is Not Crucial for Therapeutic L-Asparaginases: Antileukemic Activity of Novel Bacterial Enzymes.
    Ściuk A; Wątor K; Staroń I; Worsztynowicz P; Pokrywka K; Sliwiak J; Kilichowska M; Pietruszewska K; Mazurek Z; Skalniak A; Lewandowski K; Jaskolski M; Loch JI; Surmiak M
    Molecules; 2024 May; 29(10):. PubMed ID: 38792133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases.
    Pokrovsky VS; Kazanov MD; Dyakov IN; Pokrovskaya MV; Aleksandrova SS
    BMC Cancer; 2016 Feb; 16():89. PubMed ID: 26867931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of recent trends in research on therapeutically significant L-asparaginase and acute lymphoblastic leukemia.
    Suresh SA; Ethiraj S; Rajnish KN
    Mol Biol Rep; 2022 Dec; 49(12):11281-11287. PubMed ID: 35816224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desirable L-asparaginases for treating cancer and current research trends.
    Tsegaye K; Tsehai BA; Getie B
    Front Microbiol; 2024; 15():1269282. PubMed ID: 38591038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial L-asparaginase as a promising enzyme for treatment of various cancers.
    Darvishi F; Jahanafrooz Z; Mokhtarzadeh A
    Appl Microbiol Biotechnol; 2022 Sep; 106(17):5335-5347. PubMed ID: 35871694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial l-asparaginases for cancer therapy: Current knowledge and future perspectives.
    Ghasemian A; Al-Marzoqi AH; Al-Abodi HR; Alghanimi YK; Kadhum SA; Shokouhi Mostafavi SK; Fattahi A
    J Cell Physiol; 2019 Nov; 234(11):19271-19279. PubMed ID: 30993718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical review on properties and applications of microbial l-asparaginases.
    Krishnapura PR; Belur PD; Subramanya S
    Crit Rev Microbiol; 2016 Sep; 42(5):720-37. PubMed ID: 25865363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of development of side effects and drug resistance to asparaginase and ways to overcome them].
    Alexandrova SS; Gladilina YA; Pokrovskaya MV; Sokolov NN; Zhdanov DD
    Biomed Khim; 2022 Apr; 68(2):104-116. PubMed ID: 35485484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What makes a good new therapeutic L-asparaginase?
    Beckett A; Gervais D
    World J Microbiol Biotechnol; 2019 Sep; 35(10):152. PubMed ID: 31552479
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.